ATNNF yields 1.73% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 7
Combined, ATNNF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ATNNF + JNJ for your $10,000?
Autoneum Holding AG develops and manufactures acoustic and thermal management solutions for the automotive market. It offers multifunctional and lightweight components and systems for noise and heat protection. The company provides engine and e-motor encapsulations, frunks, outer dashes, hoodliners, engine top covers, engine and body-mounted absorbers, and outer trunk floor insulators; and underbody products, including under floor and under engine shields, wheelhouse outer liners, outer tunnel and floor insulators, battery electromagnetic shields, under battery shields, and heatshields, as well as battery and spare wheel pans. It also offers interior floor products comprising inner dashes, needle punch and tufted carpets, floor insulators and mats, inner wheelhouse and trunk floor insulators, and dampers; and other components, such as ultra-silent for underbody systems, di-light for carpet systems, prime-light and IFP-R2 for inner dashes and floor insulators, hybrid-acoustics PET for conventional insulation, mono-liner for wheelhouse outer liners, and relive-1 under the Autoneum Pure label; and measurement systems, as well as performs simulations and tests. The company has operations in Europe, North America, Asia, South America, the Middle East, and Africa. Autoneum Holding AG was founded in 1901 and is headquartered in Winterthur, Switzerland.
Full ATNNF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.